Check out Pro
Top CompaniesRecent TradesCluster BuysSectorsBlog
Join the Insiderviz Pro waitlist
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
21 Sep 2023
Randhawa Simrat
Chief Medical Officer, Officer
Dianthus Therapeutics, Inc. /DE/
(DNTH)
4,000+100%
4,000
$13.20
$52,800.00
BUY
19 Sep 2023
Fairmount Funds Management LLC
Director, 10% Owner
Dianthus Therapeutics, Inc. /DE/
(DNTH)
1,873,833+1%
30,000
$13.20
$396,000.00
BUY
11 Sep 2023
Fairmount Funds Management LLC
Director, 10% Owner
Dianthus Therapeutics, Inc. /DE/
(DNTH)
1,843,833+1%
24,254
$11.20
$271,679.88
SELL
7 Feb 2023
Third Rock Ventures IV, L.P.
10% Owner
Magenta Therapeutics, Inc.
(MGTA)
3,058,204-54%
3,700,000
$0.83
$3,056,000.00
SELL
16 Sep 2021
GARDNER JASON
See Remarks, Officer
Magenta Therapeutics, Inc.
(MGTA)
286,872-4%
14,340
$6.73
$96,508.20
SELL
16 Sep 2021
Olson Lisa
See Remarks, Officer
Magenta Therapeutics, Inc.
(MGTA)
14,264-28%
5,736
$6.73
$38,603.28
SELL
16 Sep 2021
Stants Kristen
Chief People Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
14,264-28%
5,736
$6.73
$38,603.28
SELL
16 Sep 2021
Mahoney Stephen F.
See Remarks, Officer
Magenta Therapeutics, Inc.
(MGTA)
14,264-28%
5,736
$6.73
$38,603.28
SELL
16 Sep 2021
Deardorf Caren
Chief Commercial Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
13,762-31%
6,238
$6.73
$41,981.74
SELL
16 Sep 2021
Beetham Thomas W.
See Remarks, Officer
Magenta Therapeutics, Inc.
(MGTA)
13,897-30%
6,103
$6.73
$41,073.19
SELL
16 Sep 2021
Nichols David Wayne
Chief Technical Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
14,306-28%
5,694
$6.73
$38,320.62
BUY
29 Jun 2020
Booth Bruce
Director
Magenta Therapeutics, Inc.
(MGTA)
1,250,000+100%
1,250,000
$8.00
$10,000,000.00
SELL
10 Jan 2020
GARDNER JASON
See Remarks, Director, Officer
Magenta Therapeutics, Inc.
(MGTA)
251,212-4%
11,200
$15.25
$170,800.00
SELL
2 Jan 2020
GARDNER JASON
See Remarks, Director, Officer
Magenta Therapeutics, Inc.
(MGTA)
262,412-1%
2,800
$15.10
$42,280.00
SELL
2 Jan 2020
DAVIS JOHN C. JR
Chief Medical Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
8,304-57%
11,294
$15.04
$169,816.60
SELL
24 Dec 2019
ISACSON CHRISTINA K.
Chief Business Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
83,786-5%
4,463
$16.01
$71,452.63
SELL
24 Dec 2019
ZDRAVESKI ZORAN
See Remarks, Officer
Magenta Therapeutics, Inc.
(MGTA)
128,009-5%
7,902
$16.00
$126,432.00
SELL
23 Dec 2019
GARDNER JASON
See Remarks, Director, Officer
Magenta Therapeutics, Inc.
(MGTA)
265,212-1%
2,897
$15.10
$43,754.55
SELL
23 Dec 2019
ZDRAVESKI ZORAN
See Remarks, Officer
Magenta Therapeutics, Inc.
(MGTA)
135,911-2%
4,181
$16.03
$67,021.43
SELL
23 Dec 2019
ISACSON CHRISTINA K.
Chief Business Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
88,249-10%
9,867
$16.03
$158,168.02
SELL
20 Dec 2019
GARDNER JASON
See Remarks, Director, Officer
Magenta Therapeutics, Inc.
(MGTA)
268,109-22%
76,711
$15.16
$1,162,616.60
SELL
20 Dec 2019
DAVIS JOHN C. JR
Chief Medical Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
8,304-9%
919
$15.00
$13,785.00
SELL
10 Dec 2019
GARDNER JASON
See Remarks, Director, Officer
Magenta Therapeutics, Inc.
(MGTA)
344,820-1%
4,392
$15.10
$66,319.20
SELL
9 Dec 2019
DAVIS JOHN C. JR
Chief Medical Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
8,304-72%
21,669
$15.00
$325,035.00
SELL
2 Dec 2019
COOKE MICHAEL P.
Chief Scientific Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
244,396-2%
7,500
$13.00
$97,520.02
SELL
20 Nov 2019
COOKE MICHAEL P.
Chief Scientific Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
248,023-1%
5,000
$12.00
$60,000.00
SELL
1 Nov 2019
COOKE MICHAEL P.
Chief Scientific Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
253,023-1%
5,000
$10.67
$53,333.50
SELL
1 Oct 2019
COOKE MICHAEL P.
Chief Scientific Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
258,023-1%
5,000
$10.01
$50,064.00
SELL
19 Sep 2019
COOKE MICHAEL P.
Chief Scientific Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
263,023-0%
1,656
$12.00
$19,872.00
SELL
12 Sep 2019
COOKE MICHAEL P.
Chief Scientific Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
264,679-0%
844
$12.00
$10,128.00
SELL
3 Sep 2019
COOKE MICHAEL P.
Chief Scientific Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
265,523-1%
5,000
$10.11
$50,531.00
SELL
1 Aug 2019
COOKE MICHAEL P.
Chief Scientific Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
273,023-2%
7,500
$13.42
$100,631.00
SELL
1 Jul 2019
COOKE MICHAEL P.
Chief Scientific Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
280,523-2%
7,500
$14.40
$107,983.00
SELL
21 Jun 2019
ISACSON CHRISTINA K.
Chief Business Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
98,116-5%
5,415
$16.07
$87,019.05
SELL
20 Jun 2019
GARDNER JASON
See Remarks, Director, Officer
Magenta Therapeutics, Inc.
(MGTA)
349,212-3%
14,000
$15.11
$211,523.31
SELL
17 Jun 2019
COOKE MICHAEL P.
Chief Scientific Officer, Officer
Magenta Therapeutics, Inc.
(MGTA)
285,523-2%
7,500
$13.90
$104,267.25
SELL
20 Mar 2019
Atlas Venture Fund X, L.P.
10% Owner
Magenta Therapeutics, Inc.
(MGTA)
0-100%
14,245
$17.86
$254,415.70
SELL
20 Mar 2019
Booth Bruce
Director
Magenta Therapeutics, Inc.
(MGTA)
0-100%
14,245
$17.86
$254,415.70
BUY
25 Jun 2018
GARDNER JASON
See Remarks, Director, Officer
Magenta Therapeutics, Inc.
(MGTA)
363,212+0%
400
$15.00
$6,000.00
BUY
25 Jun 2018
Scadden David
Director
Magenta Therapeutics, Inc.
(MGTA)
228,175+2%
6,600
$15.00
$99,000.00
Home
Top CompaniesForm ScreenerSectors
DisclaimersPrivacyTerms of Service
ContactBlogNewsletter